世界の急性細菌性皮膚＆皮膚組織感染症（ABSSSI）治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-3756 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、127ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、急性細菌性皮膚＆皮膚組織感染症（ABSSSI）治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（デラフロキサシン、バンコマイシン、セフタロリンフォサミル、その他）、用途別市場規模（蜂巣炎、膿瘍、外科的創傷、外傷性創傷）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・急性細菌性皮膚＆皮膚組織感染症（ABSSSI）治療の市場動向 ・企業の競争状況、市場シェア ・急性細菌性皮膚＆皮膚組織感染症（ABSSSI）治療の種類別市場規模と予測2016-2027（デラフロキサシン、バンコマイシン、セフタロリンフォサミル、その他） ・急性細菌性皮膚＆皮膚組織感染症（ABSSSI）治療の用途別市場規模と予測2016-2027（蜂巣炎、膿瘍、外科的創傷、外傷性創傷） ・急性細菌性皮膚＆皮膚組織感染症（ABSSSI）治療の北米市場規模2016-2027（アメリカ、カナダ） ・急性細菌性皮膚＆皮膚組織感染症（ABSSSI）治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・急性細菌性皮膚＆皮膚組織感染症（ABSSSI）治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・急性細菌性皮膚＆皮膚組織感染症（ABSSSI）治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・急性細菌性皮膚＆皮膚組織感染症（ABSSSI）治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Furiex Pharmaceuticals, Inc.、GlaxoSmithKline plc、Melinta Therapeutics, Inc.、Debiopharm International S.A.、MerLion Pharmaceuticals Pte Ltd.、Durata Therapeutics, Inc.、Paratek Pharmaceuticals, Inc.、Cempra, Inc.、Abbott Laboratories, Inc.、Actelion Pharmaceuticals Ltd.、Albany Molecular Research, Inc.、Allergan plc.、AstraZeneca、Bayer AG、Macrolide Pharmaceuticals, Inc.、Merck & Co, Inc.、Pfizer, Inc.、Sanofi、Teva Pharmaceuticals Industries Ltd.、Zavante Therapeutics, Inc.） ・結論

According to market experts acute skin and skin structure infections (ABSSSI) comprise set of bacterial infections that involve multiple layers of the skin and associated tissues. These infections tend to be more severe in nature than simple infections of the skin, and they usually require systemic antibacterial therapy and patient hospitalization.

Market Analysis and Insights: Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market
The global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment market.

Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Scope and Market Size
Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Delafloxacin
Vancomycin
Ceftaroline Fosamil
Others

Segment by Application
Cellulitis
Abscess
Surgical Wounds
Traumatic Wound

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Furiex Pharmaceuticals, Inc.
GlaxoSmithKline plc
Melinta Therapeutics, Inc.
Debiopharm International S.A.
MerLion Pharmaceuticals Pte Ltd.
Durata Therapeutics, Inc.
Paratek Pharmaceuticals, Inc.
Cempra, Inc.
Abbott Laboratories, Inc.
Actelion Pharmaceuticals Ltd.
Albany Molecular Research, Inc.
Allergan plc.
AstraZeneca
Bayer AG
Macrolide Pharmaceuticals, Inc.
Merck & Co, Inc.
Pfizer, Inc.
Sanofi
Teva Pharmaceuticals Industries Ltd.
Zavante Therapeutics, Inc.

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Delafloxacin
1.2.3 Vancomycin
1.2.4 Ceftaroline Fosamil
1.2.5 Others
1.3 Market by Application
1.3.1 Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Cellulitis
1.3.3 Abscess
1.3.4 Surgical Wounds
1.3.5 Traumatic Wound
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Perspective (2016-2027)
2.2 Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Growth Trends by Regions
2.2.1 Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Industry Dynamic
2.3.1 Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Trends
2.3.2 Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Drivers
2.3.3 Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Challenges
2.3.4 Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Players by Revenue
3.1.1 Global Top Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Players by Revenue (2016-2021)
3.1.2 Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue
3.4 Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Concentration Ratio
3.4.1 Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue in 2020
3.5 Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Key Players Head office and Area Served
3.6 Key Players Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Product Solution and Service
3.7 Date of Enter into Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Breakdown Data by Type
4.1 Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Historic Market Size by Type (2016-2021)
4.2 Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Forecasted Market Size by Type (2022-2027)

5 Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Breakdown Data by Application
5.1 Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Historic Market Size by Application (2016-2021)
5.2 Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size (2016-2027)
6.2 North America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Type
6.2.1 North America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Type (2016-2021)
6.2.2 North America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Type (2022-2027)
6.2.3 North America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Type (2016-2027)
6.3 North America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Application
6.3.1 North America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Application (2016-2021)
6.3.2 North America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Application (2022-2027)
6.3.3 North America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Application (2016-2027)
6.4 North America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Country
6.4.1 North America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Country (2016-2021)
6.4.2 North America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size (2016-2027)
7.2 Europe Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Type
7.2.1 Europe Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Type (2016-2021)
7.2.2 Europe Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Type (2022-2027)
7.2.3 Europe Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Type (2016-2027)
7.3 Europe Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Application
7.3.1 Europe Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Application (2016-2021)
7.3.2 Europe Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Application (2022-2027)
7.3.3 Europe Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Application (2016-2027)
7.4 Europe Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Country
7.4.1 Europe Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Country (2016-2021)
7.4.2 Europe Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size (2016-2027)
8.2 Asia-Pacific Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Type
8.2.1 Asia-Pacific Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Application
8.3.1 Asia-Pacific Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Region
8.4.1 Asia-Pacific Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size (2016-2027)
9.2 Latin America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Type
9.2.1 Latin America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Type (2016-2027)
9.3 Latin America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Application
9.3.1 Latin America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Application (2016-2027)
9.4 Latin America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Country
9.4.1 Latin America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size (2016-2027)
10.2 Middle East & Africa Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Type
10.2.1 Middle East & Africa Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Application
10.3.1 Middle East & Africa Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Country
10.4.1 Middle East & Africa Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Furiex Pharmaceuticals, Inc.
11.1.1 Furiex Pharmaceuticals, Inc. Company Details
11.1.2 Furiex Pharmaceuticals, Inc. Business Overview
11.1.3 Furiex Pharmaceuticals, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Introduction
11.1.4 Furiex Pharmaceuticals, Inc. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2016-2021)
11.1.5 Furiex Pharmaceuticals, Inc. Recent Development
11.2 GlaxoSmithKline plc
11.2.1 GlaxoSmithKline plc Company Details
11.2.2 GlaxoSmithKline plc Business Overview
11.2.3 GlaxoSmithKline plc Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Introduction
11.2.4 GlaxoSmithKline plc Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2016-2021)
11.2.5 GlaxoSmithKline plc Recent Development
11.3 Melinta Therapeutics, Inc.
11.3.1 Melinta Therapeutics, Inc. Company Details
11.3.2 Melinta Therapeutics, Inc. Business Overview
11.3.3 Melinta Therapeutics, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Introduction
11.3.4 Melinta Therapeutics, Inc. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2016-2021)
11.3.5 Melinta Therapeutics, Inc. Recent Development
11.4 Debiopharm International S.A.
11.4.1 Debiopharm International S.A. Company Details
11.4.2 Debiopharm International S.A. Business Overview
11.4.3 Debiopharm International S.A. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Introduction
11.4.4 Debiopharm International S.A. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2016-2021)
11.4.5 Debiopharm International S.A. Recent Development
11.5 MerLion Pharmaceuticals Pte Ltd.
11.5.1 MerLion Pharmaceuticals Pte Ltd. Company Details
11.5.2 MerLion Pharmaceuticals Pte Ltd. Business Overview
11.5.3 MerLion Pharmaceuticals Pte Ltd. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Introduction
11.5.4 MerLion Pharmaceuticals Pte Ltd. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2016-2021)
11.5.5 MerLion Pharmaceuticals Pte Ltd. Recent Development
11.6 Durata Therapeutics, Inc.
11.6.1 Durata Therapeutics, Inc. Company Details
11.6.2 Durata Therapeutics, Inc. Business Overview
11.6.3 Durata Therapeutics, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Introduction
11.6.4 Durata Therapeutics, Inc. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2016-2021)
11.6.5 Durata Therapeutics, Inc. Recent Development
11.7 Paratek Pharmaceuticals, Inc.
11.7.1 Paratek Pharmaceuticals, Inc. Company Details
11.7.2 Paratek Pharmaceuticals, Inc. Business Overview
11.7.3 Paratek Pharmaceuticals, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Introduction
11.7.4 Paratek Pharmaceuticals, Inc. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2016-2021)
11.7.5 Paratek Pharmaceuticals, Inc. Recent Development
11.8 Cempra, Inc.
11.8.1 Cempra, Inc. Company Details
11.8.2 Cempra, Inc. Business Overview
11.8.3 Cempra, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Introduction
11.8.4 Cempra, Inc. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2016-2021)
11.8.5 Cempra, Inc. Recent Development
11.9 Abbott Laboratories, Inc.
11.9.1 Abbott Laboratories, Inc. Company Details
11.9.2 Abbott Laboratories, Inc. Business Overview
11.9.3 Abbott Laboratories, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Introduction
11.9.4 Abbott Laboratories, Inc. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2016-2021)
11.9.5 Abbott Laboratories, Inc. Recent Development
11.10 Actelion Pharmaceuticals Ltd.
11.10.1 Actelion Pharmaceuticals Ltd. Company Details
11.10.2 Actelion Pharmaceuticals Ltd. Business Overview
11.10.3 Actelion Pharmaceuticals Ltd. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Introduction
11.10.4 Actelion Pharmaceuticals Ltd. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2016-2021)
11.10.5 Actelion Pharmaceuticals Ltd. Recent Development
11.11 Albany Molecular Research, Inc.
11.11.1 Albany Molecular Research, Inc. Company Details
11.11.2 Albany Molecular Research, Inc. Business Overview
11.11.3 Albany Molecular Research, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Introduction
11.11.4 Albany Molecular Research, Inc. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2016-2021)
11.11.5 Albany Molecular Research, Inc. Recent Development
11.12 Allergan plc.
11.12.1 Allergan plc. Company Details
11.12.2 Allergan plc. Business Overview
11.12.3 Allergan plc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Introduction
11.12.4 Allergan plc. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2016-2021)
11.12.5 Allergan plc. Recent Development
11.13 AstraZeneca
11.13.1 AstraZeneca Company Details
11.13.2 AstraZeneca Business Overview
11.13.3 AstraZeneca Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Introduction
11.13.4 AstraZeneca Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2016-2021)
11.13.5 AstraZeneca Recent Development
11.14 Bayer AG
11.14.1 Bayer AG Company Details
11.14.2 Bayer AG Business Overview
11.14.3 Bayer AG Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Introduction
11.14.4 Bayer AG Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2016-2021)
11.14.5 Bayer AG Recent Development
11.15 Macrolide Pharmaceuticals, Inc.
11.15.1 Macrolide Pharmaceuticals, Inc. Company Details
11.15.2 Macrolide Pharmaceuticals, Inc. Business Overview
11.15.3 Macrolide Pharmaceuticals, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Introduction
11.15.4 Macrolide Pharmaceuticals, Inc. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2016-2021)
11.15.5 Macrolide Pharmaceuticals, Inc. Recent Development
11.16 Merck & Co, Inc.
11.16.1 Merck & Co, Inc. Company Details
11.16.2 Merck & Co, Inc. Business Overview
11.16.3 Merck & Co, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Introduction
11.16.4 Merck & Co, Inc. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2016-2021)
11.16.5 Merck & Co, Inc. Recent Development
11.17 Pfizer, Inc.
11.17.1 Pfizer, Inc. Company Details
11.17.2 Pfizer, Inc. Business Overview
11.17.3 Pfizer, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Introduction
11.17.4 Pfizer, Inc. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2016-2021)
11.17.5 Pfizer, Inc. Recent Development
11.18 Sanofi
11.18.1 Sanofi Company Details
11.18.2 Sanofi Business Overview
11.18.3 Sanofi Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Introduction
11.18.4 Sanofi Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2016-2021)
11.18.5 Sanofi Recent Development
11.18 Teva Pharmaceuticals Industries Ltd.
.1 Teva Pharmaceuticals Industries Ltd. Company Details
.2 Teva Pharmaceuticals Industries Ltd. Business Overview
.3 Teva Pharmaceuticals Industries Ltd. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Introduction
.4 Teva Pharmaceuticals Industries Ltd. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2016-2021)
.5 Teva Pharmaceuticals Industries Ltd. Recent Development
11.20 Zavante Therapeutics, Inc.
11.20.1 Zavante Therapeutics, Inc. Company Details
11.20.2 Zavante Therapeutics, Inc. Business Overview
11.20.3 Zavante Therapeutics, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Introduction
11.20.4 Zavante Therapeutics, Inc. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2016-2021)
11.20.5 Zavante Therapeutics, Inc. Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Delafloxacin
Table 3. Key Players of Vancomycin
Table 4. Key Players of Ceftaroline Fosamil
Table 5. Key Players of Others
Table 6. Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Share by Regions (2016-2021)
Table 10. Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Share by Regions (2022-2027)
Table 12. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Trends
Table 13. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Drivers
Table 14. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Challenges
Table 15. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Restraints
Table 16. Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Share by Players (2016-2021)
Table 18. Global Top Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment as of 2020)
Table 19. Ranking of Global Top Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Product Solution and Service
Table 23. Date of Enter into Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue Market Share by Type (2016-2021)
Table 27. Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue Market Share by Application (2016-2021)
Table 31. Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 63. Furiex Pharmaceuticals, Inc. Company Details
Table 64. Furiex Pharmaceuticals, Inc. Business Overview
Table 65. Furiex Pharmaceuticals, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Product
Table 66. Furiex Pharmaceuticals, Inc. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2016-2021) & (US$ Million)
Table 67. Furiex Pharmaceuticals, Inc. Recent Development
Table 68. GlaxoSmithKline plc Company Details
Table 69. GlaxoSmithKline plc Business Overview
Table 70. GlaxoSmithKline plc Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Product
Table 71. GlaxoSmithKline plc Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2016-2021) & (US$ Million)
Table 72. GlaxoSmithKline plc Recent Development
Table 73. Melinta Therapeutics, Inc. Company Details
Table 74. Melinta Therapeutics, Inc. Business Overview
Table 75. Melinta Therapeutics, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Product
Table 76. Melinta Therapeutics, Inc. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2016-2021) & (US$ Million)
Table 77. Melinta Therapeutics, Inc. Recent Development
Table 78. Debiopharm International S.A. Company Details
Table 79. Debiopharm International S.A. Business Overview
Table 80. Debiopharm International S.A. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Product
Table 81. Debiopharm International S.A. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2016-2021) & (US$ Million)
Table 82. Debiopharm International S.A. Recent Development
Table 83. MerLion Pharmaceuticals Pte Ltd. Company Details
Table 84. MerLion Pharmaceuticals Pte Ltd. Business Overview
Table 85. MerLion Pharmaceuticals Pte Ltd. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Product
Table 86. MerLion Pharmaceuticals Pte Ltd. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2016-2021) & (US$ Million)
Table 87. MerLion Pharmaceuticals Pte Ltd. Recent Development
Table 88. Durata Therapeutics, Inc. Company Details
Table 89. Durata Therapeutics, Inc. Business Overview
Table 90. Durata Therapeutics, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Product
Table 91. Durata Therapeutics, Inc. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2016-2021) & (US$ Million)
Table 92. Durata Therapeutics, Inc. Recent Development
Table 93. Paratek Pharmaceuticals, Inc. Company Details
Table 94. Paratek Pharmaceuticals, Inc. Business Overview
Table 95. Paratek Pharmaceuticals, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Product
Table 96. Paratek Pharmaceuticals, Inc. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2016-2021) & (US$ Million)
Table 97. Paratek Pharmaceuticals, Inc. Recent Development
Table 98. Cempra, Inc. Company Details
Table 99. Cempra, Inc. Business Overview
Table 100. Cempra, Inc. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2016-2021) & (US$ Million)
Table 101. Cempra, Inc. Recent Development
Table 102. Abbott Laboratories, Inc. Company Details
Table 103. Abbott Laboratories, Inc. Business Overview
Table 104. Abbott Laboratories, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Product
Table 105. Abbott Laboratories, Inc. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2016-2021) & (US$ Million)
Table 106. Abbott Laboratories, Inc. Recent Development
Table 107. Actelion Pharmaceuticals Ltd. Company Details
Table 108. Actelion Pharmaceuticals Ltd. Business Overview
Table 109. Actelion Pharmaceuticals Ltd. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Product
Table 110. Actelion Pharmaceuticals Ltd. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2016-2021) & (US$ Million)
Table 111. Actelion Pharmaceuticals Ltd. Recent Development
Table 112. Albany Molecular Research, Inc. Company Details
Table 113. Albany Molecular Research, Inc. Business Overview
Table 114. Albany Molecular Research, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Product
Table 115. Albany Molecular Research, Inc. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2016-2021) & (US$ Million)
Table 116. Albany Molecular Research, Inc. Recent Development
Table 117. Allergan plc. Company Details
Table 118. Allergan plc. Business Overview
Table 119. Allergan plc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Product
Table 120. Allergan plc. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2016-2021) & (US$ Million)
Table 121. Allergan plc. Recent Development
Table 122. AstraZeneca Company Details
Table 123. AstraZeneca Business Overview
Table 124. AstraZeneca Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Product
Table 125. AstraZeneca Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2016-2021) & (US$ Million)
Table 126. AstraZeneca Recent Development
Table 127. Bayer AG Company Details
Table 128. Bayer AG Business Overview
Table 129. Bayer AG Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Product
Table 130. Bayer AG Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2016-2021) & (US$ Million)
Table 131. Bayer AG Recent Development
Table 132. Macrolide Pharmaceuticals, Inc. Company Details
Table 133. Macrolide Pharmaceuticals, Inc. Business Overview
Table 134. Macrolide Pharmaceuticals, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Product
Table 135. Macrolide Pharmaceuticals, Inc. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2016-2021) & (US$ Million)
Table 136. Macrolide Pharmaceuticals, Inc. Recent Development
Table 137. Merck & Co, Inc. Company Details
Table 138. Merck & Co, Inc. Business Overview
Table 139. Merck & Co, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Product
Table 140. Merck & Co, Inc. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2016-2021) & (US$ Million)
Table 141. Merck & Co, Inc. Recent Development
Table 142. Pfizer, Inc. Company Details
Table 143. Pfizer, Inc. Business Overview
Table 144. Pfizer, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Product
Table 145. Pfizer, Inc. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2016-2021) & (US$ Million)
Table 146. Pfizer, Inc. Recent Development
Table 147. Sanofi Company Details
Table 148. Sanofi Business Overview
Table 149. Sanofi Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Product
Table 150. Sanofi Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2016-2021) & (US$ Million)
Table 151. Sanofi Recent Development
Table 152. Teva Pharmaceuticals Industries Ltd. Company Details
Table 153. Teva Pharmaceuticals Industries Ltd. Business Overview
Table 154. Teva Pharmaceuticals Industries Ltd. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Product
Table 155. Teva Pharmaceuticals Industries Ltd. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2016-2021) & (US$ Million)
Table 156. Teva Pharmaceuticals Industries Ltd. Recent Development
Table 157. Zavante Therapeutics, Inc. Company Details
Table 158. Zavante Therapeutics, Inc. Business Overview
Table 159. Zavante Therapeutics, Inc. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Product
Table 160. Zavante Therapeutics, Inc. Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2016-2021) & (US$ Million)
Table 161. Zavante Therapeutics, Inc. Recent Development
Table 162. Research Programs/Design for This Report
Table 163. Key Data Information from Secondary Sources
Table 164. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Share by Type: 2020 VS 2027
Figure 2. Delafloxacin Features
Figure 3. Vancomycin Features
Figure 4. Ceftaroline Fosamil Features
Figure 5. Others Features
Figure 6. Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Share by Application: 2020 VS 2027
Figure 7. Cellulitis Case Studies
Figure 8. Abscess Case Studies
Figure 9. Surgical Wounds Case Studies
Figure 10. Traumatic Wound Case Studies
Figure 11. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Report Years Considered
Figure 12. Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Share by Regions: 2020 VS 2027
Figure 15. Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Share by Regions (2022-2027)
Figure 16. Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Share by Players in 2020
Figure 17. Global Top Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue in 2020
Figure 19. Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue Market Share by Type (2016-2021)
Figure 20. Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Revenue Market Share by Type (2022-2027)
Figure 21. North America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Share by Type (2016-2027)
Figure 23. North America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Share by Application (2016-2027)
Figure 24. North America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Share by Country (2016-2027)
Figure 25. United States Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Share by Type (2016-2027)
Figure 29. Europe Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Share by Application (2016-2027)
Figure 30. Europe Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Share by Country (2016-2027)
Figure 31. Germany Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Share by Region (2016-2027)
Figure 41. China Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Share by Type (2016-2027)
Figure 49. Latin America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Share by Application (2016-2027)
Figure 50. Latin America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Share by Country (2016-2027)
Figure 51. Mexico Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Share by Country (2016-2027)
Figure 57. Turkey Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Furiex Pharmaceuticals, Inc. Revenue Growth Rate in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2016-2021)
Figure 61. GlaxoSmithKline plc Revenue Growth Rate in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2016-2021)
Figure 62. Melinta Therapeutics, Inc. Revenue Growth Rate in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2016-2021)
Figure 63. Debiopharm International S.A. Revenue Growth Rate in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2016-2021)
Figure 64. MerLion Pharmaceuticals Pte Ltd. Revenue Growth Rate in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2016-2021)
Figure 65. Durata Therapeutics, Inc. Revenue Growth Rate in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2016-2021)
Figure 66. Paratek Pharmaceuticals, Inc. Revenue Growth Rate in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2016-2021)
Figure 67. Cempra, Inc. Revenue Growth Rate in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2016-2021)
Figure 68. Abbott Laboratories, Inc. Revenue Growth Rate in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2016-2021)
Figure 69. Actelion Pharmaceuticals Ltd. Revenue Growth Rate in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2016-2021)
Figure 70. Albany Molecular Research, Inc. Revenue Growth Rate in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2016-2021)
Figure 71. Allergan plc. Revenue Growth Rate in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2016-2021)
Figure 72. AstraZeneca Revenue Growth Rate in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2016-2021)
Figure 73. Bayer AG Revenue Growth Rate in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2016-2021)
Figure 74. Macrolide Pharmaceuticals, Inc. Revenue Growth Rate in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2016-2021)
Figure 75. Merck & Co, Inc. Revenue Growth Rate in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2016-2021)
Figure 76. Pfizer, Inc. Revenue Growth Rate in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2016-2021)
Figure 77. Sanofi Revenue Growth Rate in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2016-2021)
Figure 78. Teva Pharmaceuticals Industries Ltd. Revenue Growth Rate in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2016-2021)
Figure 79. Zavante Therapeutics, Inc. Revenue Growth Rate in Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Business (2016-2021)
Figure 80. Bottom-up and Top-down Approaches for This Report
Figure 81. Data Triangulation
Figure 82. Key Executives Interviewed

---